Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians

2024-9-12

Options for patients with out-of-control blood pressure: after all avenues have been exhausted

2024-9-11

Lipoprotein(a) in interventional cardiology: identifying patients at highest risk of recurrent cardiovascular events through early recognition – a case based review

2024-9-11

Beyond pulmonary vein isolation: approaches to treat patients with persistent atrial fibrillation

2024-9-6

Closing the gap between guidelines and clinical practice for managing dyslipidemia: where are we now?

2024-8-28

PTSD and mood disorders in implantable cardioverter defibrillator patients: is more psychological assessment needed?

2024-8-1

In-hospital cardiac arrest after STEMI: prevention strategies and post-arrest care

2024-7-30

Cerebral embolic protection for stroke prevention during transcatheter aortic valve replacement

2024-7-26

Long-term outcomes following bioresorbable vascular scaffolds

2024-7-25

Challenges and solutions to implementing cardiac rehabilitation in a low- and middle-income country

2024-7-16

Current status and future directions in artificial intelligence for nuclear cardiology

2024-7-13

A novel balloon-expandable transcatheter aortic valve bioprosthesis: myval and myval Octacor

2024-7-2

The dual chamber leadless pacemaker: a game changer for bradycardia management?

2024-7-2

Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation

2024-7-1

Ischemic stroke and the emerging role of left atrial function

2024-6-29

The role of statin therapy in older adults: best practices and unmet challenges

2024-6-28

Population-based approaches for reducing stroke risk: an update on their success and the challenges ahead

2024-6-24

Evaluating current assessment techniques of cardiorespiratory fitness

2024-6-2

The role of gut microbiota in the development of salt sensitive hypertension and the possible preventive effect of exercise

2024-6-2

Targeting obesity for therapeutic intervention in heart failure patients

2024-6-2

Sex differences in acute myocardial infarction

2024-5-30

Managing chronic coronary syndrome: how do we achieve optimal patient outcomes?

2024-5-20

Role of anticoagulation in non-ST-elevation myocardial infarction: a contemporary narrative review

2024-5-14

Safety of cardiovascular disease drugs approved between 2014 and 2021 in the US: a pharmacovigilance analysis

2024-5-9

Aveir VR leadless pacemaker: interview with professor Tom Wong

2024-5-3

Angiographic patterns in spontaneous coronary artery dissection: novel diagnostic insights

2024-4-29

How will coronary physiology, plaque vulnerability and ischemia be integrated in future patient pathways with chest pain?

2024-4-28

The best of ‘best buys’: public health values of potassium-enriched salt substitute

2024-4-27

Cardiovascular disease and risk in COPD: a state of the art review

2024-3-26

Pulmonary vascular disease and optical coherence tomography imaging in patients with Fontan palliation

2024-3-25

Navigating the prime editing strategy to treat cardiovascular genetic disorders in transforming heart health

2024-3-17

Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report

2024-3-14

Sex differences in trends and in-hospital outcomes of acute myocardial infarction in patients with familial hypercholesterolemia: insights from a large national database

2024-3-12

Physical activity, exercise and adverse cardiovascular outcomes in individuals with pre-existing cardiovascular disease: a narrative review

2024-3-3

Rural and urban hospitals in the United States: does location affect care and outcomes of patients with heart failure?

2024-3-3

When to ablate in Brugada and early repolarization syndromes

2024-3-3

Should patients with diabetes be routinely screened for atrial fibrillation?

2024-3-3

A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials

2024-2-28

Original algorithms for the detection of cardiovascular involvement of neglected tropical diseases

2024-2-3

The clinical characteristics, managements, and outcomes of acute myocardial infarction in osteoarthritis patients; a cross-sectional analysis of 6.5 million patients

2024-1-29

Sex differences in trends and outcomes of acute myocardial infarction with mechanical complications in the United States

2024-1-29

Preventive cardiology for the aging population: how can we better design clinical trials of statins?

2024-1-23

Trends and cardiovascular outcomes of Takotsubo syndrome with cardiogenic shock vs. mixed cardiogenic and septic shock: a nationwide propensity matched analysis

2023-12-18

Risk factors modification in atrial fibrillation: a brief review

2023-12-18

Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches

2023-12-2

Contemporary applications of multimodality imaging in infective endocarditis

2023-11-29

PCSK9 inhibitors: current status and emerging frontiers in lipid control

2023-11-24

Reducing bleeding risk in patients on oral anticoagulation therapy

2023-11-8

Bivalirudin in acute coronary syndromes

2023-11-7

Should atrial fibrillation be considered a vascular disease? The need for a comprehensive vascular approach

2023-11-2